Lancaster Heart and Stroke Foundation, Lancaster, Pennsylvania, USA.
J Card Fail. 2009 Aug;15(6):475-81. doi: 10.1016/j.cardfail.2009.01.012. Epub 2009 Mar 17.
Acute decreases in intrathoracic impedance monitoring have been shown to precede heart failure hospitalization in a limited population of heart failure patients. We evaluated the relationship between changes in intrathoracic impedance with hospitalizations associated with acute decompensated heart failure (ADHF) in patients with cardiac resynchronization therapy plus defibrillator (CRT-D) devices.
The study enrolled 326 heart failure patients who had received CRT-D with impedance-monitoring capabilities (InSync Sentry, Medtronic). The date and duration of ADHF hospitalizations were retrospectively identified before device interrogation to obtain device diagnostic information. During 333 +/- 96 days of device monitoring, 228 patients experienced 540 intrathoracic impedance fluid index threshold crossings events (TCE) at the nominal threshold value (60 Omega. days). During the initial 4-month evaluation period, 17 subjects experienced 22 ADHF hospitalizations. In the subsequent monitoring period (206 +/- 95 days), 18 patients experienced 24 hospitalizations. The occurrence of TCEs during the monitoring period was independently correlated with the subsequent rate of ADHF hospitalization such that each TCE event during the risk stratification period was associated with a 35% increased risk for ADHF hospitalization in the remaining study period (P = .001). Poisson regression indicated that the subgroup of patients with an annual average rate of more than 3 threshold crossings per year during the monitoring period were significantly more likely to be hospitalized for ADHF than those patients with no TCE during the monitoring period (0.76 [0.20-1.325] vs. 0.14 [0.05-0.23] hospitalizations/subject/y [95%CI]; P = .02). Likewise, Kaplan-Meier analysis revealed that subsets of patients with more than 3 TCEs per year or with more than 30 days per year above threshold during the risk stratification period had significantly higher rates of ADHF hospitalization during the post risk stratification period than subjects with no TCE events, respectively.
In this multicenter retrospective cohort study, serial decreases in intrathoracic impedance sufficient to generate a fluid index threshold crossing as well as the net duration that the index remained above threshold during a 4-month monitoring period were associated with subsequent risk of ADHF hospitalization.
在有限的心力衰竭患者群体中,已经证明胸腔内阻抗监测的急性下降先于心力衰竭住院。我们评估了与心脏再同步治疗除颤器 (CRT-D) 装置相关的急性失代偿性心力衰竭 (ADHF) 住院患者的胸腔内阻抗变化之间的关系。
该研究纳入了 326 名接受过 CRT-D 且具有阻抗监测功能的心力衰竭患者(InSync Sentry,美敦力)。在进行设备检测之前,回顾性地确定 ADHF 住院的日期和持续时间,以获取设备诊断信息。在 333±96 天的设备监测期间,228 名患者在名义阈值(60Ω.天)处经历了 540 次胸腔内阻抗液体指数阈值穿越事件(TCE)。在最初的 4 个月评估期间,17 名患者经历了 22 次 ADHF 住院。在随后的监测期间(206±95 天),18 名患者经历了 24 次住院。监测期间 TCE 的发生与随后的 ADHF 住院率独立相关,以至于风险分层期间的每次 TCE 事件都与剩余研究期间 ADHF 住院风险增加 35%相关(P=0.001)。泊松回归表明,在监测期间每年平均超过 3 次阈值穿越率的亚组患者比在监测期间没有 TCE 的患者更有可能因 ADHF 住院(0.76[0.20-1.325]与 0.14[0.05-0.23]住院/患者/年[95%CI];P=0.02)。同样,Kaplan-Meier 分析表明,在风险分层期间每年 TCE 超过 3 次或每年超过 30 天超过阈值的亚组患者在风险分层后期间的 ADHF 住院率明显高于无 TCE 事件的患者。
在这项多中心回顾性队列研究中,连续胸腔内阻抗下降足以产生液体指数阈值穿越,以及在 4 个月监测期间该指数保持在阈值以上的净时间与随后的 ADHF 住院风险相关。